ArticleFrontiers in oncology2020

Integration of the B-Cell Receptor Antigen Neurabin-I/SAMD14 Into an Antibody Format as New Therapeutic Approach for the Treatment of Primary CNS Lymphoma.

Moritz Bewarder et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.